Literature DB >> 7205775

Reproduction in Brattleboro rats with diabetes insipidus.

K Boer, G J Boer, D F Swaab.   

Abstract

The Brattleboro diabetes insipidus mutant is incapable of synthesizing vasopressin, but is activated in its production and release of oxytocin. In the homozygous female mutant, there were abnormally short and long oestrous cycles and reduced conception rates after mating with mutant males, a shortened gestation length, and a shorter time-course of labour. A better conception rate when mutant females were mated with normal Brattleboro males indicates the involvement of a male factor in the subfertility. The reduced litter size in diabetes insipidus rats appeared neither dependent of the male's genotype, nor due to a decreased viability of diabetes insipidus fetuses.

Entities:  

Mesh:

Year:  1981        PMID: 7205775     DOI: 10.1530/jrf.0.0610273

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  4 in total

Review 1.  The role of kisspeptin and RFamide-related peptide-3 neurones in the circadian-timed preovulatory luteinising hormone surge.

Authors:  A R Khan; A S Kauffman
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 2.  Clocks on top: the role of the circadian clock in the hypothalamic and pituitary regulation of endocrine physiology.

Authors:  Karen J Tonsfeldt; Patrick E Chappell
Journal:  Mol Cell Endocrinol       Date:  2011-07-20       Impact factor: 4.102

Review 3.  Neuroendocrine mechanisms underlying estrogen positive feedback and the LH surge.

Authors:  Alexander S Kauffman
Journal:  Front Neurosci       Date:  2022-07-27       Impact factor: 5.152

4.  Female fertility does not require Bmal1 in suprachiasmatic nucleus neurons expressing arginine vasopressin, vasoactive intestinal peptide, or neuromedin-S.

Authors:  Karen J Tonsfeldt; Laura J Cui; Jinkwon Lee; Thijs J Walbeek; Liza E Brusman; Ye Jin; Michihiro Mieda; Michael R Gorman; Pamela L Mellon
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.